Aspen Pharmacare Holdings Limited (JSE:APN)

Aspen Pharmacare Holdings Balance Sheet

Financials in millions ZAR. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	6,409	12,337	10,912	6,183	8,546
Trading Asset Securities	-	-	-	-	9
Cash & Short-Term Investments	6,409	12,337	10,912	6,183	8,555
Cash Growth	-48.05%	13.06%	76.48%	-27.73%	20.51%
Accounts Receivable	10,646	10,299	10,087	8,243	7,698
Other Receivables	3,352	3,200	3,537	4,036	2,739
Receivables	13,998	13,499	13,624	12,279	10,437
Inventory	18,009	18,002	19,606	15,763	13,409
Prepaid Expenses	271	242	344	336	235
Other Current Assets	15	6	14	-	69
Total Current Assets	38,702	44,086	44,500	34,561	32,705
Property, Plant & Equipment	21,707	20,509	18,897	16,224	15,226
Goodwill	5,202	5,696	5,596	5,007	4,621
Other Intangible Assets	65,389	65,255	62,282	52,664	53,530
Long-Term Deferred Tax Assets	2,222	1,794	1,579	1,252	1,323
Long-Term Deferred Charges	1,823	771	822	987	1,352
Other Long-Term Assets	848	952	608	680	927
Total Assets	135,893	139,063	134,284	111,375	109,684
Accounts Payable	4,084	4,372	3,969	3,641	3,297
Accrued Expenses	5,975	5,314	5,404	5,468	4,980
Short-Term Debt	-	5,117	3,419	1,212	2,591
Current Portion of Long-Term Debt	4,356	5,923	4,325	10,329	21,884
Current Portion of Leases	256	274	163	124	165
Current Income Taxes Payable	385	791	900	613	563
Current Unearned Revenue	-	8	13	43	78
Other Current Liabilities	2,440	2,503	4,955	1,965	3,193
Total Current Liabilities	17,496	24,302	23,148	23,395	36,751
Long-Term Debt	31,263	24,819	21,103	10,361	-
Long-Term Leases	245	322	272	221	266
Long-Term Unearned Revenue	-	-	-	10	51
Long-Term Deferred Tax Liabilities	446	1,582	1,995	1,966	1,810
Other Long-Term Liabilities	812	2,476	840	3,898	4,449
Total Liabilities	51,000	54,202	48,048	40,433	44,057
Common Stock	2,017	2,017	2,017	2,017	2,089
Retained Earnings	58,092	60,763	58,134	54,341	50,756
Treasury Stock	-363	-364	-348	-233	-214
Comprehensive Income & Other	25,147	22,445	26,433	14,817	12,996
Total Common Equity	84,893	84,861	86,236	70,942	65,627
Shareholders' Equity	84,893	84,861	86,236	70,942	65,627
Total Liabilities & Equity	135,893	139,063	134,284	111,375	109,684
Total Debt	36,120	36,455	29,282	22,247	24,906
Net Cash (Debt)	-29,711	-24,118	-18,370	-16,064	-16,351
Net Cash Per Share	-66.92	-54.30	-41.36	-35.46	-35.82
Filing Date Shares Outstanding	444.02	444.21	444.95	444.95	455.16
Total Common Shares Outstanding	444.02	444.21	444.95	444.95	455.16
Working Capital	21,206	19,784	21,352	11,166	-4,046
Book Value Per Share	191.19	191.04	193.81	159.44	144.18
Tangible Book Value	14,302	13,910	18,358	13,271	7,476
Tangible Book Value Per Share	32.21	31.31	41.26	29.83	16.42
Land	868	800	834	628	541
Buildings	7,199	7,033	6,744	7,056	6,470
Machinery	13,646	11,889	11,067	10,756	9,326
Construction In Progress	8,492	7,698	6,530	4,647	4,427

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.